PhaseBio Pharmaceuticals, Inc.

PHAS · NASDAQ
Analyze with AI
$0.0701+$0.00 (+0%)
At close:Nov 2, 2022, 8:00 PM UTC
P/E TTM-15.72
P/B TTM-0.02
P/S TTM0
Dividend Yield0%
EPS-$2.38
Beta2.869146
Valuation
PEG Ratio-0.16
FCF Yield–
EV / EBITDA-20.42
More On Valuation »
Quality
ROIC-0.35%
Gross Margin100.00%
Cash Conv. Ratio-2.11
More On Quality »
Growth
Revenue 3Y CAGR-83.38%
FCF Growth18.37%
More On Growth »
Safety
Net Debt / EBITDA-20.42
Interest Coverage137.72
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00
More On Efficiency »

PhaseBio Pharmaceuticals, Inc. (PHAS) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is PhaseBio Pharmaceuticals, Inc. (PHAS) stock price today?

As of Nov 2, 2022, 8:00 PM UTC, PhaseBio Pharmaceuticals, Inc. (PHAS) stock is trading at $0.0701. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date PHAS stock quotes for informed trading decisions.

What is PhaseBio Pharmaceuticals, Inc.'s market capitalization?

Current market capitalization data for PhaseBio Pharmaceuticals, Inc. (PHAS) is not available at this moment. Market cap depends on the latest share count and stock price from Financial Modeling Prep. This information typically updates after regulatory filings are processed.

What is the 52-week range for PhaseBio Pharmaceuticals, Inc. stock?

PhaseBio Pharmaceuticals, Inc. (PHAS) stock has traded in a 52-week range of $0.041 — $4.08. The 52-week range shows the highest and lowest prices at which PHAS traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current PhaseBio Pharmaceuticals, Inc. stock price to this range provides context for recent price action.

How much trading volume does PhaseBio Pharmaceuticals, Inc. stock have?

PhaseBio Pharmaceuticals, Inc. (PHAS) stock recently traded approximately 8.6M shares. Trading volume indicates market liquidity and investor interest in PHAS. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting PhaseBio Pharmaceuticals, Inc. stock.

Does PhaseBio Pharmaceuticals, Inc. pay dividends to shareholders?

Yes, PhaseBio Pharmaceuticals, Inc. (PHAS) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate PhaseBio Pharmaceuticals, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is PhaseBio Pharmaceuticals, Inc.'s intraday price range?

Today, PhaseBio Pharmaceuticals, Inc. (PHAS) stock has traded in a range of $0.0665 — $0.092. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring PHAS's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get PhaseBio Pharmaceuticals, Inc. stock data?

AlphaPilot sources real-time PHAS stock quotes, fundamental financial data, and historical price charts for PhaseBio Pharmaceuticals, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The PhaseBio Pharmaceuticals, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of PHAS stock performance.